BUZZ — India's Zydus Lifesciences falls after US FDA inspection ends with five observations

* Shares of pharmaceuticals company Zydus Lifesciences fell as much as 2.03% to 1,109.50 rupees * US FDA closed inspection at co's Ahmedabad manufacturing plant with five observations, co said * ZYDU closely working with FDA to address observations--statement * Stock's F12M PE ratio of 24.98 vs industry median of 25.98--LSEG-compiled data * 29 analysts, on average, rate the stock "hold", median TP at 1,205 rupees--LSEG-compiled data * YTD, shares up 21.65% (Reporting by Saikeerthi in Bengaluru) ((Saikeerthi@thomsonreuters.com;)